Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas
Background: The implementation of gene therapy for the treatment of pituitary tumors emerges as a promising complement to surgery and may have distinct advantages over radiotherapy for this type of tumors. Up to now, suicide gene therapy has been the main experimental approach explored to treat expe...
Guardado en:
| Autores principales: | Cónsole-Avegliano, Gloria Miriam, Hereñú, Claudia Beatriz, Camihort, Gisela, Luna, Georgina Cecilia, Bracamonte, María, Morel, Gustavo Ramón, Goya, Rodolfo Gustavo |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2008
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/35097 http://www.molecular-cancer.com/content/pdf/1476-4598-7-13.pdf |
| Aporte de: |
Ejemplares similares
-
Morphological changes induced by insulin-like growth factor-I gene therapy in pituitary cell populations in experimental prolactinomas
por: Camihort, Gisela, et al.
Publicado: (2010) -
Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats
por: Morel, Gustavo Ramón, et al.
Publicado: (2010) -
PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes
por: Cristina, C., et al. -
Caracterización del sistema TGF-ß1 hipofisario : en búsqueda de un blanco terapéutico para prolactinomas resistentes a agonistas dopaminérgicos
por: Recouvreux, María Victoria
Publicado: (2012) -
Caracterización del sistema TGF-ß1 hipofisario : en búsqueda de un blanco terapéutico para prolactinomas resistentes a agonistas dopaminérgicos
por: Recouvreux, María Victoria
Publicado: (2012)